Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Urinary Bladder Neoplasms × Aminolevulinic Acid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Keratosis, Actinic 5 Skin Diseases 2 Precancerous Conditions 2 Urinary Bladder Neoplasms 1 Ovarian Neoplasms 1 Meningioma 1 Glioma 1 Carcinoma, Basal Cell 1 Breast Neoplasms 1 Brain Neoplasms 1

Interventions

Gemcitabine 23 Cisplatin 21 Mitomycin 16 BCG Vaccine 11 Paclitaxel 8 Doxorubicin 7 Docetaxel 7 5-aminolevulinic acid hexyl ester 7 pembrolizumab 6 vinflunine 5 apaziquone 5 Vinblastine 5 Radiotherapy 5 Methotrexate 5 Magnetic Resonance Spectroscopy 5 Carboplatin 5 durvalumab 4 atezolizumab 4 Fluorouracil 4 enfortumab vedotin 3 Transurethral Resection of Bladder 3 Surgical Procedures, Operative 3 Specimen Handling 3 Selenium 3 Radiation 3 Nivolumab 3 Filgrastim 3 Cystoscopy 3 Cystectomy 3 BCG Connaught 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02101931 2016-03-31

ALA

Princess Al-Johara Al-Ibrahim Cancer Research Center

Phase 3 Completed

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡